UNSPSC 51284509: Lincomycin hydrochloride monohydrate

This classification denotes a lincosamide antibiotic with the molecular formula C18H34N2O6S.ClH.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M6T05Z2B68, chemically known as lincolnensin, hydrochloride, hemihydrate but more generally known as lincomycin hydrochloride, which bears US NIH Compound Identifier 3928. European Medicines Agency schedules Lincomycin hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02924MIG.

Most nations, for tariff and trade purposes, schedule lincomycin hydrochloride monohydrate under HS 29419000 and SITC 54139. SMILES: CCC[C@@H]1C[C@H](N(C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@@H](C)O.O.CL.

UNSPSC 51284509 Lincomycin hydrochloride monohydrate is a Commodity code that sees minimal recent state and local procurement activity directly aligned with its nominal scope. The recent opportunities tagged under this code diverge substantially from the specific pharmaceutical product named — the solicitations posted between January and June 2026 address broader medical and pharmaceutical procurement categories including naloxone and drug deactivation systems, generic multi-source pharmaceuticals and OTC products, and direct-to-manufacturer prescription programs, rather than lincomycin hydrochloride specifically. The mix of issuing bodies spans state health agencies, county health departments, municipal fire departments, and cooperative purchasing alliances; the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) and Texas Health and Human Services Commission represent state-level procurement infrastructure, while Seminole County (Florida) and the City of Tampa represent county and municipal health operations. Work being solicited includes emergency medical supplies for fire-rescue operations, pharmaceutical distribution through authorized wholesalers, and exploratory direct-to-manufacturer contracting models for state pharmacy benefit programs.

Recent opportunities cluster in Florida, Texas, and Minnesota. The City of Tampa's IFB 26P00145 (posted March 2026, response due March 13, 2026) solicited 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division with an estimated contract value of $700,000, designated as a sheltered-market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount. The Minnesota Multistate Cooperative Purchasing Alliance issued RFP S1070000015802 (posted January 2026, proposals due March 26, 2026) to establish multiple contracts for generic pharmaceuticals and OTC products distributed across state and local facilities in Minnesota and Oregon, with awards effective July 1, 2026. Seminole County, Florida released IFB 60459723LAS (posted June 2026, due July 26, 2023) for 1,900 units of naloxone and 800 drug deactivation systems annually, and the Texas Health and Human Services Commission issued RFI HHS0017013 (April 2026) to gather vendor capabilities on direct-to-manufacturer prescription programs. The code shows little relevant recent activity; procurement under it does not target lincomycin hydrochloride as a specific line item in current solicitations.